- Home
- LNTH vs TAC Comparison
LNTH vs TAC Comparison
Compare LNTH & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- TAC
- Stock Information
- Founded
- LNTH 1956
- TAC 1909
- Country
- LNTH United States
- TAC Canada
- Employees
- LNTH N/A
- TAC N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TAC Electric Utilities: Central
- Sector
- LNTH Health Care
- TAC Utilities
- Exchange
- LNTH Nasdaq
- TAC Nasdaq
- Market Cap
- LNTH 3.6B
- TAC 3.2B
- IPO Year
- LNTH 2015
- TAC N/A
- Fundamental
- Price
- LNTH $52.94
- TAC $12.64
- Analyst Decision
- LNTH Strong Buy
- TAC Buy
- Analyst Count
- LNTH 5
- TAC 3
- Target Price
- LNTH $91.60
- TAC $19.83
- AVG Volume (30 Days)
- LNTH 1.5M
- TAC 921.4K
- Earning Date
- LNTH 11-05-2025
- TAC 11-04-2025
- Dividend Yield
- LNTH N/A
- TAC 1.41%
- EPS Growth
- LNTH N/A
- TAC N/A
- EPS
- LNTH 3.77
- TAC N/A
- Revenue
- LNTH $1,520,653,000.00
- TAC $1,838,165,207.00
- Revenue This Year
- LNTH N/A
- TAC N/A
- Revenue Next Year
- LNTH $3.24
- TAC N/A
- P/E Ratio
- LNTH $14.03
- TAC N/A
- Revenue Growth
- LNTH 5.75
- TAC N/A
- 52 Week Low
- LNTH $47.25
- TAC $7.82
- 52 Week High
- LNTH $118.21
- TAC $14.64
- Technical
- Relative Strength Index (RSI)
- LNTH 38.79
- TAC 59.94
- Support Level
- LNTH $51.94
- TAC $11.94
- Resistance Level
- LNTH $55.24
- TAC $12.82
- Average True Range (ATR)
- LNTH 1.97
- TAC 0.27
- MACD
- LNTH 0.48
- TAC 0.02
- Stochastic Oscillator
- LNTH 14.89
- TAC 78.98
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.